Wednesday, November 18, 2009

Methotrexate

Antifolate antimetabolite used in both benign and malignant diseases.  Notably IBD, Breast ca, SCC and sarcomas.
- inhibits dihydrofolate reductase preventing nucleotide synthesis

Myelosuppression is the most common SE and is dose-limiting

No comments:

Post a Comment